Evaluation of 192Ir-Based Hypofractionated Stereotactic Ablative Brachytherapy as A Neoadjuvant Treatment for Operable Peripheral Non-small Cell Lung Cancer

Evaluation of 192Ir-Based Hypofractionated Stereotactic Ablative Brachytherapy as A Neoadjuvant Treatment for Operable Peripheral Non-small Cell Lung Cancer

Objective To evaluate the safety, feasibility and efficacy of template-assisted 192Ir-based hypofractionated stereotactic ablative brachytherapy (SABT) combined with surgery for peripheral non-small cell lung cancer (NSCLC) patients. Methods We enrolled the patients who were pathologically confirmed...

Full description

Bibliographic Details
Main Authors: SHI Xiangxiang, PANG Haowen, SUN Xiaoyang, REN Peirong, WU Jingbo, LIN Sheng
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2019-02-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
brachytherapy
neoadjuvant
non-small cell lung cancer
safety
efficacy
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2019.18.1112.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2019.18.1112.htm

Similar Items